HRP20100302T1 - Sinteza inzulinotropnog peptida - Google Patents

Sinteza inzulinotropnog peptida Download PDF

Info

Publication number
HRP20100302T1
HRP20100302T1 HR20100302T HRP20100302T HRP20100302T1 HR P20100302 T1 HRP20100302 T1 HR P20100302T1 HR 20100302 T HR20100302 T HR 20100302T HR P20100302 T HRP20100302 T HR P20100302T HR P20100302 T1 HRP20100302 T1 HR P20100302T1
Authority
HR
Croatia
Prior art keywords
amino acid
seq
side chain
fragment
acid sequence
Prior art date
Application number
HR20100302T
Other languages
English (en)
Croatian (hr)
Inventor
Chen Lin
Han Yeun-Kwei
R. Roberts Christopher
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20100302T1 publication Critical patent/HRP20100302T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR20100302T 2006-06-23 2007-06-19 Sinteza inzulinotropnog peptida HRP20100302T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81591906P 2006-06-23 2006-06-23
PCT/EP2007/056052 WO2007147816A1 (en) 2006-06-23 2007-06-19 Insulinotropic peptide synthesis

Publications (1)

Publication Number Publication Date
HRP20100302T1 true HRP20100302T1 (hr) 2010-06-30

Family

ID=38596729

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100302T HRP20100302T1 (hr) 2006-06-23 2007-06-19 Sinteza inzulinotropnog peptida

Country Status (33)

Country Link
US (2) US20080004429A1 (pl)
EP (1) EP2035451B1 (pl)
JP (1) JP4537495B2 (pl)
KR (1) KR101087859B1 (pl)
CN (1) CN101563364B (pl)
AR (1) AR061604A1 (pl)
AT (1) ATE466881T1 (pl)
AU (1) AU2007263043B2 (pl)
BR (1) BRPI0713575A2 (pl)
CA (1) CA2654610C (pl)
CL (1) CL2007001835A1 (pl)
CR (1) CR10463A (pl)
CY (1) CY1110186T1 (pl)
DE (1) DE602007006310D1 (pl)
DK (1) DK2035451T3 (pl)
EC (1) ECSP088999A (pl)
ES (1) ES2341588T3 (pl)
HR (1) HRP20100302T1 (pl)
IL (1) IL195421A0 (pl)
MA (1) MA30530B1 (pl)
MX (1) MX2008015935A (pl)
MY (1) MY144608A (pl)
NO (1) NO20084863L (pl)
NZ (1) NZ573093A (pl)
PL (1) PL2035451T3 (pl)
PT (1) PT2035451E (pl)
RS (1) RS51281B (pl)
RU (1) RU2448978C2 (pl)
SI (1) SI2035451T1 (pl)
TW (1) TWI331155B (pl)
UA (1) UA96602C2 (pl)
WO (1) WO2007147816A1 (pl)
ZA (1) ZA200810072B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
WO2009074483A2 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20100317057A1 (en) * 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
EP2424888A2 (en) * 2009-05-01 2012-03-07 F. Hoffmann-La Roche AG Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20110313131A1 (en) 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
EP2788110B1 (en) * 2011-12-08 2018-10-17 Pentair Water Pool and Spa, Inc. Aquaculture system and method of operating a pump in such a system
ES2682253T3 (es) 2011-12-29 2018-09-19 Novo Nordisk A/S Dipéptido que comprende un aminoácido no proteogénico
CN104936610A (zh) 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
CN119060201A (zh) * 2018-03-09 2024-12-03 费森尤斯卡比有限公司 利拉鲁肽、索马鲁肽和glp-1的化学酶促合成
EP3762408A1 (en) 2018-03-09 2021-01-13 Enzypep B.V. Chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1
EP3864032B1 (en) * 2018-10-09 2022-11-30 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of glp-1 analogues
TWI799680B (zh) 2019-01-29 2023-04-21 美商美國禮來大藥廠 製備gip/glp1雙重促效劑之方法
TWI738260B (zh) * 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
US12269844B2 (en) 2019-03-25 2025-04-08 Scinopharm Taiwan, Ltd. Process for purifying semaglutide and liraglutide
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US20220324936A1 (en) * 2019-06-18 2022-10-13 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of glucagon
US20230406900A1 (en) * 2022-06-01 2023-12-21 Scinopharm Taiwan, Ltd. Process for preparing glucagon-like peptide-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
JPH11503454A (ja) * 1995-04-14 1999-03-26 ジ アドミニストレイターズ オブ ザ チューレン エデュケイショナル ファンド 成長ホルモン放出因子の類似体
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
WO2000034331A2 (en) * 1998-12-07 2000-06-15 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Analogues of glp-1
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP1701970A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support

Also Published As

Publication number Publication date
ZA200810072B (en) 2009-12-30
CN101563364A (zh) 2009-10-21
DE602007006310D1 (pl) 2010-06-17
IL195421A0 (en) 2011-08-01
CY1110186T1 (el) 2015-01-14
US20110213082A1 (en) 2011-09-01
KR20090023619A (ko) 2009-03-05
US20080004429A1 (en) 2008-01-03
RU2448978C2 (ru) 2012-04-27
NZ573093A (en) 2012-01-12
CN101563364B (zh) 2014-04-02
DK2035451T3 (da) 2010-06-07
ES2341588T3 (es) 2010-06-22
CR10463A (es) 2009-02-26
AU2007263043A1 (en) 2007-12-27
TW200811195A (en) 2008-03-01
NO20084863L (no) 2009-01-22
EP2035451A1 (en) 2009-03-18
MX2008015935A (es) 2009-01-13
WO2007147816A1 (en) 2007-12-27
ATE466881T1 (de) 2010-05-15
CL2007001835A1 (es) 2008-03-14
JP2009541257A (ja) 2009-11-26
KR101087859B1 (ko) 2011-11-30
CA2654610C (en) 2012-03-20
ECSP088999A (es) 2009-01-30
TWI331155B (en) 2010-10-01
SI2035451T1 (sl) 2010-06-30
AR061604A1 (es) 2008-09-10
PT2035451E (pt) 2010-06-09
AU2007263043B2 (en) 2012-11-29
CA2654610A1 (en) 2007-12-27
RS51281B (sr) 2010-12-31
MA30530B1 (fr) 2009-06-01
MY144608A (en) 2011-10-14
RU2009101969A (ru) 2010-07-27
EP2035451B1 (en) 2010-05-05
JP4537495B2 (ja) 2010-09-01
BRPI0713575A2 (pt) 2013-02-13
PL2035451T3 (pl) 2010-08-31
UA96602C2 (ru) 2011-11-25

Similar Documents

Publication Publication Date Title
RU2009101969A (ru) Синтез инсулинотропных пептидов
Bycroft et al. A novel lysine-protecting procedure for continuous flow solid phase synthesis of branched peptides
Kawakami et al. Peptide thioester preparation based on an NS acyl shift reaction mediated by a thiol ligation auxiliary
KR101904808B1 (ko) 데가렐릭스 및 이의 중간 화합물의 제조 방법
WO2016140232A1 (ja) ペプチド合成方法
CN109195618A (zh) 用于合成α4β7肽拮抗剂的方法
RU2008135440A (ru) Водорастворимые аналоги ссс-1065 и их конъюгаты
US8377891B2 (en) Process for synthesis of cyclic octapeptide
RU2010128247A (ru) Синтез инсулинотропных пептидов с помощью комбинированных твердофазных и растворных методик
RU2010107283A (ru) Способ получения пептида
JP2007514752A5 (pl)
EA201100802A1 (ru) Синтез пептидов с использованием энзиматической активации и конденсации
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
US4438103A (en) Organic compounds
GB1521919A (en) Process for the manufacture of human insulin
JP2001342200A (ja) オクトレオチドとその誘導体の製法
CN106349336B (zh) 一种酶法合成环肽的方法
CS199708B2 (en) Method of producing polypeptides and derivatives thereof having effect similar morphine
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
Itoh et al. Control of the cytotoxicity of dansylated polytheonamide mimic, an artificial peptide ion channel, by modification of the N-terminal structure
CN106831950A (zh) 一种制备利那洛肽的方法
Bogdán et al. Toward the green synthesis of peptides and peptidic drugs
Rodrigues et al. Synthesis and conformational investigation of tetrapeptide analogues of the fragment B23-B26 of insulin
FOTOUHI et al. Resolution of proline acylation problem for thiol capture strategy by use of a chloro‐dibenzofuran template
KR20170014624A (ko) Tdm-621의 제조방법